Mitsubishi Chemical Holdings, Japan’s largest chemical maker, has named Jean-Marc Gilson, CEO of plant-ingredients maker Roquette Frères (Lestrem, France), as its next CEO, effective 1 April 2021. Gilson, a Belgian-US dual citizen, will take over the role from Hitoshi Ochi. Gilson previously held senior leadership roles at Dow Corning and Avantor.
Mitsubishi Chemical said it searched globally for candidates, both inside and external, after Ochi expressed his intent to retire at the end of Mitsubishi Chemical’s current fiscal year, which coincides with the end of the company’s current medium-term management plan.
Mitsubishi Chemical outside director Takayuki Hashimoto, chair of the nominating committee, said the criteria for evaluation included an ability to build a strategic vision and strategy, foreseeing the post-COVID 19 world, that integrates the company’s healthcare business with the high-value added chemicals and performance materials; capability of improving corporate value particularly from the perspective of shareholders and investors; and the ability to “decisively implement portfolio transformation through strong leadership.”
Hashimoto said three internal and four external candidates were evaluated. “Given his performance, competencies and enthusiasm to lead the company, we determined that Jean-Marc Gilson is the optimal choice to lead [Mitsubishi Chemical] realizing our vision of sustainable growth by accelerating our portfolio transformation and globally undertaking initiatives to solve social issues based on the group philosophy,” Mitsubishi Chemical said in a statement.
JSR Corp. (Tokyo) last year appointed American Eric Johnson, previously president of JSR Micro and general manager of its life sciences business, as CEO.
By Kartik Kohli
Source: chemweek.com
This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.
Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.
